Split 9th Circ. Won't Revive IRhythm Securities Fraud Suit

A split Ninth Circuit declined Wednesday to revive an iRhythm Technologies investor's securities suit alleging the company made misrepresentations about Medicare's process for setting reimbursement rates for iRhythm's heart monitor patch,...

Already a subscriber? Click here to view full article